OB/GYN perceptions of prescription drug monitoring programs as a primary prevention tool for neonatal abstinence syndrome

Joshua D. Brown, P. Chris Delcher, Jungjun Bae, Dikea Roussos-Ross, Amie J. Goodin

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Background: The U.S. Centers for Disease Control and Prevention recommend clinicians use Prescription Drug Monitoring Program (PDMPs) as a risk assessment tool for opioid-related harms. This survey assessed perceptions of PDMPs for the purpose of Neonatal Abstinence Syndrome (NAS) prevention among a national sample of obstetricians-gynecologists (OB/GYNs) who are the primary care providers for most pregnancies. Methods: A survey was emailed to a random sample of active American College of Obstetricians and Gynecologists (ACOG) members. Proxy data for the intensity of the opioid epidemic and state policies related to NAS were added to respondents survey answers. Chi-squared analyses were used to compare response frequencies. Results: Among 397 submitted responses, nearly 70% identified PDMPs having a role in preventing diversion and opioid use disorders but only 25.1% identified PDMPs as a tool to prevent NAS. States with stricter NAS policies (e.g. child abuse, mandatory testing) generally had higher positive responses for PDMPs’ role in preventing NAS. States with voluntary PDMP use versus mandatory reported higher positive responses for PDMPs with NAS but differences were not statistically significant (30.6% vs. 23.8%, p = 0.374). State-specific measures of the overall intensity of the opioid epidemic were not associated with perceptions of PDMP. Conclusions: OB/GYNs do not associate PDMPs as a primary prevention tool against NAS despite endorsements. Tailored educational interventions to this practice environment are needed. Pharmacist engagement with pregnant patients and as champions of PDMP usage may help fill these gaps.

Original languageEnglish
Pages (from-to)1789-1791
Number of pages3
JournalResearch in Social and Administrative Pharmacy
Issue number12
StatePublished - Dec 2020

Bibliographical note

Publisher Copyright:
© 2020 Elsevier Inc.


  • Neonatal abstinence syndrome
  • OB/GYNs
  • Opioid use disorder
  • Prescription drug monitoring programs

ASJC Scopus subject areas

  • Pharmacy
  • Pharmaceutical Science


Dive into the research topics of 'OB/GYN perceptions of prescription drug monitoring programs as a primary prevention tool for neonatal abstinence syndrome'. Together they form a unique fingerprint.

Cite this